Sort
25,944 grants matching “neurodegeneration”
T lymphocyte-induced glial activation during CNS immune reconstitution disease
$380,000James R Lokensgard · University Of Minnesota · R01 · FY2017 · MH
Vascular and Neuronal Repair with Adipose Stromal Cells in Retinopathy
$380,000Rajashekhar Gangaraju · University Of Tennessee Health Sci Ctr · R01 · FY2017 · EY
Effects of glycomacropeptide on memory and Alzheimer-related neuropathology
$380,000Michael P McDonald · University Of Tennessee Health Sci Ctr · R01 · FY2017 · AG
Dynamics of calcium signals control neurotransmitter release in retinal ribbon synapses
$380,000Thirumalini Vaithianathan · University Of Tennessee Health Sci Ctr · R01 · FY2025 · EY
Synucleins: Cell biology and transgenic mice
$380,000Michael K Lee · University Of Minnesota · R56 · FY2012 · NS
Dynamics of calcium signals control neurotransmitter release in retinal ribbon synapses
$380,000Thirumalini Vaithianathan · University Of Tennessee Health Sci Ctr · R01 · FY2023 · EY
Molecular Mechanisms of Neurodegeneration
$380,000Alexander Gow · Wayne State University · R01 · FY2009 · NS
Ubiquitin Signaling
$379,970Peter Kaiser · University Of California-Irvine · R01 · FY2020 · GM
Characterization and reversal of neurocognitive dysfunction produced by long-term synthetic cathinone use
$379,952M. Foster Olive · Arizona State University-Tempe Campus · R01 · FY2017 · DA
Neuroprotective role of GLP-1 receptor agonists
$379,940Nigel H. Greig · National Institute On Aging · ZIA · FY2014 · AG
Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia
$379,932Yuna Ayala · Saint Louis University · R01 · FY2022 · NS
Transcriptional Regulation of BACE and the Components of the gamma-Secretase Comp
$379,882Huaxi Xu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · AG
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD
$379,863Etty N. Benveniste · University Of Alabama At Birmingham · P50 · FY2019 · NS
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD
$379,862Etty N. Benveniste · University Of Alabama At Birmingham · P50 · FY2021 · NS
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD
$379,862Etty N. Benveniste · University Of Alabama At Birmingham · P50 · FY2022 · NS
BRAIN PROTEIN OXIDATION IN AD, MCI, AND PCAD: ROLES OF AB AND PIN1
$379,775D. Allan Butterfield · University Of Kentucky · P01 · FY2009 · AG
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy
$379,750Wonkyu Ju · University Of California, San Diego · R01 · FY2014 · EY
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy
$379,750Wonkyu Ju · University Of California, San Diego · R01 · FY2015 · EY
Novel Tau-mediated Neurodegeneration Mechanisms
$379,680Adriana B Ferreira · Northwestern University At Chicago · R01 · FY2009 · NS
Translational Control by Human Pumilio Proteins
$379,675Aaron Charles Goldstrohm · University Of Minnesota · R01 · FY2023 · GM
Translational Control by Human Pumilio Proteins
$379,675Aaron Charles Goldstrohm · University Of Minnesota · R01 · FY2025 · GM
Translational Control by Human Pumilio Proteins
$379,675Aaron Charles Goldstrohm · University Of Minnesota · R01 · FY2024 · GM
Characterization and reversal of neurocognitive dysfunction produced by long-term synthetic cathinone use
$379,616M. Foster Olive · Arizona State University-Tempe Campus · R01 · FY2020 · DA
Biogenesis of macromolecular machines for post-transcriptional regulation of translation
$379,582Homa Ghalei · Emory University · R35 · FY2022 · GM
Multidisciplinary Fellowship in Alzheimerâs Disease and Related Dementias
$379,538Bruce L Miller · University Of California, San Francisco · T32 · FY2019 · AG